Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing.

Collet JP, Sharpe C, Belzile E, Boivin JF, Hanley J, Abenhaim L.

Br J Cancer. 1999 Sep;81(1):62-8.

2.

Cyclooxygenase-2 inhibitors in tumorigenesis (part I).

Taketo MM.

J Natl Cancer Inst. 1998 Oct 21;90(20):1529-36. Review.

3.
4.

Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines.

Han EK, Arber N, Yamamoto H, Lim JT, Delohery T, Pamukcu R, Piazza GA, Xing WQ, Weinstein IB.

Breast Cancer Res Treat. 1998 Apr;48(3):195-203.

PMID:
9598866
5.

Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer.

Hwang D, Scollard D, Byrne J, Levine E.

J Natl Cancer Inst. 1998 Mar 18;90(6):455-60.

6.

Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas.

Robertson FM, Parrett ML, Joarder FS, Ross M, Abou-Issa HM, Alshafie G, Harris RE.

Cancer Lett. 1998 Jan 9;122(1-2):165-75.

PMID:
9464506
7.

Recreational and occupational physical activities and risk of breast cancer.

Gammon MD, John EM, Britton JA.

J Natl Cancer Inst. 1998 Jan 21;90(2):100-17. Review.

8.
9.

Physical activity and the risk of breast cancer.

Thune I, Brenn T, Lund E, Gaard M.

N Engl J Med. 1997 May 1;336(18):1269-75.

10.

Nonsteroidal antiinflammatory drugs and breast cancer.

Harris RE, Namboodiri KK, Farrar WB.

Epidemiology. 1996 Mar;7(2):203-5.

PMID:
8834563
12.

Prospective study of regular aspirin use and the risk of breast cancer.

Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA.

J Natl Cancer Inst. 1996 Jul 17;88(14):988-93.

13.

The influence of angiogenesis research on management of patients with breast cancer.

Folkman J.

Breast Cancer Res Treat. 1995;36(2):109-18. Review.

PMID:
8534860
14.

Aspirin use and risk of fatal cancer.

Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr.

Cancer Res. 1993 Mar 15;53(6):1322-7.

15.

Incidence of cancer among patients with rheumatoid arthritis.

Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, Hoover R, Fraumeni JF Jr.

J Natl Cancer Inst. 1993 Feb 17;85(4):307-11.

PMID:
8426374
16.

Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group.

Hunter CP, Redmond CK, Chen VW, Austin DF, Greenberg RS, Correa P, Muss HB, Forman MR, Wesley MN, Blacklow RS, et al.

J Natl Cancer Inst. 1993 Jul 21;85(14):1129-37.

PMID:
8320742
17.
18.

Aspirin use and lung, colon, and breast cancer incidence in a prospective study.

Schreinemachers DM, Everson RB.

Epidemiology. 1994 Mar;5(2):138-46.

PMID:
8172988
19.

Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage cohort study.

Risch HA, Howe GR.

Am J Epidemiol. 1994 Apr 1;139(7):670-83.

PMID:
8166128
20.

Breast cancer and NSAID use: heterogeneity of effect in a case-control study.

Harris RE, Namboodiri K, Stellman SD, Wynder EL.

Prev Med. 1995 Mar;24(2):119-20. No abstract available.

PMID:
7597011
Items per page

Supplemental Content

Write to the Help Desk